These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 28324002)

  • 21. Occurrence over time and regression of nonalcoholic fatty liver disease in type 2 diabetes.
    Giorda C; Forlani G; Manti R; Mazzella N; De Cosmo S; Rossi MC; Nicolucci A; Russo G; Di Bartolo P; Ceriello A; Guida P;
    Diabetes Metab Res Rev; 2017 May; 33(4):. PubMed ID: 28032449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B virus infection and risk of non-alcoholic fatty liver disease: A population-based cohort study.
    Zhu L; Jiang J; Zhai X; Baecker A; Peng H; Qian J; Zhou M; Song C; Zhou Y; Xu J; Liu H; Hang D; Hu Z; Shen H; Zhang ZF; Zhu F
    Liver Int; 2019 Jan; 39(1):70-80. PubMed ID: 30025200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fatty liver index is a predictor of incident diabetes in patients with prediabetes: The PREDAPS study.
    Franch-Nadal J; Caballeria L; Mata-Cases M; Mauricio D; Giraldez-García C; Mancera J; Goday A; Mundet-Tudurí X; Regidor E;
    PLoS One; 2018; 13(6):e0198327. PubMed ID: 29856820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum fetuin-A concentration predicts glycaemic outcomes in people with prediabetes: a prospective study from eastern India.
    Dutta D; Mondal SA; Kumar M; Hasanoor Reza AH; Biswas D; Singh P; Chakrabarti S; Mukhopadhyay S
    Diabet Med; 2014 Dec; 31(12):1594-9. PubMed ID: 24975463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adolescent Nonalcoholic Fatty Liver Disease and Type 2 Diabetes in Young Adulthood.
    Bardugo A; Bendor CD; Zucker I; Lutski M; Cukierman-Yaffe T; Derazne E; Mosenzon O; Tzur D; Beer Z; Pinhas-Hamiel O; Ben-Ami M; Fishman B; Ben-Ami Shor D; Raz I; Afek A; Gerstein HC; Häring HU; Tirosh A; Levi Z; Twig G
    J Clin Endocrinol Metab; 2021 Jan; 106(1):e34-e44. PubMed ID: 33075820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of Lean Patients with Non-alcoholic Fatty Liver Disease in a Middle Income Country; Prevalence and Its Association with Metabolic Disorders: A Cross-sectional Study.
    Naderian M; Kolahdoozan S; Sharifi AS; Garmaroudi G; Yaseri M; Poustchi H; Sohrabpour AA
    Arch Iran Med; 2017 Apr; 20(4):211-217. PubMed ID: 28412824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Analysis of influencing factors and causes of death in elderly residents with non-alcoholic fatty liver disease].
    Xu JY; Shao Y; Lu XL; Deng J; Li XL; Shi HT
    Zhonghua Gan Zang Bing Za Zhi; 2019 Mar; 27(3):204-209. PubMed ID: 30929337
    [No Abstract]   [Full Text] [Related]  

  • 29. The association between nonalcoholic fatty pancreas disease and diabetes.
    Ou HY; Wang CY; Yang YC; Chen MF; Chang CJ
    PLoS One; 2013; 8(5):e62561. PubMed ID: 23671610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China.
    Yi M; Chen RP; Yang R; Chen H
    Diabet Med; 2017 Apr; 34(4):505-513. PubMed ID: 27334577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycemic Measures and Development and Resolution of Nonalcoholic Fatty Liver Disease in Nondiabetic Individuals.
    Wang B; Li M; Zhao Z; Wang S; Lu J; Chen Y; Xu M; Wang W; Ning G; Bi Y; Wang T; Xu Y
    J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32144419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Non-alcoholic fatty liver disease increases the incidence rate of type 2 diabetes mellitus: a cohort study based on a rural town elderly population of southern Jiangsu].
    Shao Y; Xu JY; Lu XL; Chen J; Li T; Wang YT; Shi HT
    Zhonghua Gan Zang Bing Za Zhi; 2021 Sep; 29(9):867-872. PubMed ID: 34638206
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: An 8-year follow-up study.
    Lu ZY; Shao Z; Li YL; Wulasihan M; Chen XH
    World J Gastroenterol; 2016 Apr; 22(13):3663-9. PubMed ID: 27053858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of and predictive factors for nonalcoholic fatty liver disease in Sudanese individuals with type 2 diabetes: Is metabolic syndrome the culprit?
    Almobarak AO; Barakat S; Suliman EA; Elmadhoun WM; Mohamed NA; Abobaker IO; Noor SK; Bushara SO; Ahmed MH
    Arab J Gastroenterol; 2015 Jun; 16(2):54-8. PubMed ID: 26174761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of prediabetes and diabetes vary by ethnicity among U.S. Asian adults at healthy weight, overweight, and obesity ranges: an electronic health record study.
    Vicks WS; Lo JC; Guo L; Rana JS; Zhang S; Ramalingam ND; Gordon NP
    BMC Public Health; 2022 Oct; 22(1):1954. PubMed ID: 36273116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Joint associations of metabolically healthy abdominal obesity and non-alcoholic fatty liver disease with prediabetes and diabetes in Chinese adults.
    Zhang J; Xu Q; Lai F; Chen N; Lin M; Liu Y; Zhang W; Liu C; Wang S; Li Z
    BMJ Open Diabetes Res Care; 2021 Aug; 9(1):. PubMed ID: 34433546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The diagnostics and clinical pattern of nonalcoholic fatty liver disease in patients with pre-diabetes and type 2 diabetes and obesity].
    Чубірко КІ
    Wiad Lek; 2017; 70(2):208-212. PubMed ID: 28511161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of weight status and the risks of diabetes in adults: a systematic review and meta-analysis of prospective cohort studies.
    Yu HJ; Ho M; Liu X; Yang J; Chau PH; Fong DYT
    Int J Obes (Lond); 2022 Jun; 46(6):1101-1113. PubMed ID: 35197569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Association between regional fat mass and risk of nonalcoholic fatty liver disease in overweight/obese adults].
    Zeng Y; Yuan S; Xie M; Xiao T; Huang Z; Zhou J; He Q; Yang Y; Ma J
    Wei Sheng Yan Jiu; 2022 Sep; 51(5):753-760. PubMed ID: 36222034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Morbidity and Comorbidity of Nonalcoholic Fatty Liver Disease and Different Glucose Intolerance Strata in a Community-Based Chinese Population.
    Zhang X; Zhou X; Han X; Fu Z; Wang L; Li Y; Ji L
    Metab Syndr Relat Disord; 2020 Aug; 18(6):284-290. PubMed ID: 32460629
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.